DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China flag China · Delayed Price · Currency is CNY
20.71
-0.11 (-0.53%)
Nov 18, 2026, 3:00 PM CST

SHA:603233 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
6,2416,5096,2174,4164,4932,792
Short-Term Investments
--6---
Trading Asset Securities
1,153438.9615.5141.9991.99109.37
Cash & Short-Term Investments
7,3946,9486,2384,4584,5852,902
Cash Growth
11.82%11.38%39.92%-2.76%58.01%-34.65%
Accounts Receivable
1,4211,2811,3031,2341,022743.82
Other Receivables
805.61406.51400.08436.53368.24308.18
Receivables
2,2271,6881,7031,6711,3901,052
Inventory
4,2684,1414,1284,1813,8723,630
Prepaid Expenses
-3.863.3511.9739.0343.79
Other Current Assets
695.4599.45513.27476.21783.06240.19
Total Current Assets
14,58413,38112,58610,79810,6707,868
Property, Plant & Equipment
6,6146,7607,3057,3016,0955,654
Long-Term Investments
97.23158.26155.59155.59132.16150.17
Goodwill
3,7553,4683,5223,0242,3642,060
Other Intangible Assets
1,8761,9661,9691,859637.19618.8
Long-Term Deferred Tax Assets
219.92217.8231.61214.48186.31157.57
Long-Term Deferred Charges
23.66515648.03670.03663.03669.76
Other Long-Term Assets
507.6721.7922.22101.1294.19157.99
Total Assets
27,67826,48726,44024,12320,84117,336

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
9,7679,9378,4336,8716,1274,738
Accrued Expenses
408.34690.83685.93757.54809.87488.83
Short-Term Debt
766.73543.431,982744.89697.31165.44
Current Portion of Long-Term Debt
2,6161,43542.2814.847.64-
Current Portion of Leases
-1,1071,1771,041974.67905.59
Current Income Taxes Payable
305.48199.22137.64176.21138.4198.67
Current Unearned Revenue
504.06477.63408.81362.4435.73164.11
Other Current Liabilities
1,581677.48839.681,486516.59615.14
Total Current Liabilities
15,94915,06713,70711,4549,7087,176
Long-Term Debt
777.01463.031,8461,6381,4611,252
Long-Term Leases
1,9632,2272,6973,0702,7902,952
Long-Term Unearned Revenue
14.7114.9817.4219.317.6420.12
Other Long-Term Liabilities
54.3553.4234.849.670.33-
Total Liabilities
18,75717,82618,30216,19013,97711,400

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,1391,1391,1391,139949.12790.93
Additional Paid-In Capital
1,2441,2591,2881,3551,5371,643
Retained Earnings
5,1324,8804,3814,1703,5732,933
Treasury Stock
-100.74-100.74-100.74-29.72-36.68-77.59
Comprehensive Income & Other
189.85189.92189.92189.94189.94189.96
Total Common Equity
7,6047,3686,8976,8246,2125,479
Minority Interest
1,3161,2941,2411,109652.27457.3
Shareholders' Equity
8,9208,6618,1387,9336,8645,936
Total Liabilities & Equity
27,67826,48726,44024,12320,84117,336

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
6,1225,7757,7446,5085,9315,275
Net Cash (Debt)
1,2721,173-1,506-2,050-1,346-2,373
Net Cash Growth
89.68%-----
Net Cash Per Share
1.111.03-1.33-1.81-1.18-2.10
Filing Date Shares Outstanding
1,1391,1391,1391,1391,1391,139
Total Common Shares Outstanding
1,1391,1391,1391,1391,1391,139
Working Capital
-1,365-1,687-1,121-655.27962.03692.26
Book Value Per Share
6.686.476.065.995.454.81
Tangible Book Value
1,9731,9341,4061,9413,2112,800
Tangible Book Value Per Share
1.731.701.231.702.822.46
Buildings
---2,0161,076800.43
Machinery
-1,7611,5981,4601,2571,119
Construction In Progress
-358.57487.75874.531,049765.67